A carregar...
Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist
The optimal treatment strategy for Parkinson's disease has been debated for decades. The introduction of levodopa (LD) treatment is frequently delayed because of theoretical concerns about its toxicity or the risk of drug-induced motor complications. These concerns have resulted in “LD phobia”...
Na minha lista:
| Publicado no: | Curr Neuropharmacol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bentham Science Publishers
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4876591/ https://ncbi.nlm.nih.gov/pubmed/26644151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X14666151208114634 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|